20,000 heart attack patients enrolled in landmark korean study
NCT ID NCT07409441
First seen Feb 22, 2026 · Last updated Jun 20, 2026 · Updated 17 times
Summary
This observational study will follow 20,000 Korean adults who have had a heart attack. Researchers will collect data from hospitals across Korea to understand what affects long-term survival and to develop a risk model specific to Korean patients. The goal is to improve treatment and care guidelines for this population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION, ACUTE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chonnam National University Hospital
Gwangju, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Samsung Medical Center
Seoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this registry could lead to better risk prediction and treatment guidelines tailored to Korean heart attack patients, potentially improving survival and care quality.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test a new drug or therapy. Results depend on data quality and may not apply outside Korea.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.